On June 1, more than 25,000 cancer specialists will come together at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago. With ASCO hours away, we look at some small biotech companies making headway in cancer treatment.
Biovest Seeking Marketing Approval in the EU for BiovaxID® Personalized Lymphoma Cancer Vaccine
Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed.
OneMedRadio: NanoViricides CEO Discusses U.S. Patent
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
The Technology Corner: Disruptive Technology for Prostate Cancer
In this special series we present emerging technologies which hold the promise to significantly improve the prognosis of patients diagnosed with prostate cancer, and cancer in general.
“Rockstar of Science”, Eric Topol M.D. Talks The Creative Destruction of Medicine
Author of “The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Healthcare”, Dr. Eric Topol sits down with OneMedRadio to discuss the ideas and inspiration behind the book.
NYBA Annual Meeting: The Wrap Up
The New York Biotech Association Annual Meeting last Wednesday and Thursday was a success, showcasing 15 emerging companies as well as two dozen panels over the two-day span. Held in the Marriott Marquis Hotel, a staple of Times Square, the 21st annual conference was well attended.
CIN Special Report: Part II, Treatments Ready to Eradicate Pre-Cervical Cancer
Part II of the report identifies several disruptive technologies that may overcome the challenges of mainstream treatments.
